metastatic breast cancer

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  

metastatic breast cancer
May 7, 2025, 01:14 | Science
Integrative Strategies in Palliative Care for Metastatic Breast Cancer - ABC Global Alliance
ABC Global Alliance shared an article on LinkedIn: "New video alert! Join Dr. Fatima Cardoso, President…
May 6, 2025, 10:45 | Drugs
Amol Akhade: Oral SERDs and PROTACs in ER+/HER2– Metastatic Breast Cancer - Trial Landscape Update
Amol Akhade, Senior Consultant Medical Oncologist and Hemato-Oncologist at Suyog Cancer Clinics and Reliance Hospitals, shared…
Apr 24, 2025, 10:39 | Blog
Tanja Obradovic: Improved PFS versus current SOC of taxane, trastuzumab and pertuzumab
Tanja Obradovic, Vice President of Oncology Scientific Affairs at ICON PLCh, shared a post on LinkedIn:…
Apr 23, 2025, 08:55 | Blog
Ahmed Alanazi: ADCs are now reshaping the standard of care for metastatic Breast Cancer
Ahmed Alanazi, Department Program Director at King Fahad Medical City, shared a post on X: "ADCs…
Apr 21, 2025, 10:45 | Blog
Kristina Jankovic: DESTINY-Breast09 - Enhertu plus Pertuzumab Tops THP in 1L HER2+ metastatic breast cancer
Kristina Jankovic, Medical Oncology Resident at University Clinical Center Nis, shared a post on X:…
Apr 21, 2025, 08:07 | Blog
Matthew Kurian: DESTINY-Breast09 may change the landscape of first-line treatment for HER2+ MBC
Matthew Kurian, Physician at St. Elizabeth Healthcare and Assistant Professor of Medicine at the University…
Apr 20, 2025, 19:09 | Science
Hope Rugo: Congratulations to Laura Huppert on the multicenter study of sequential ADC use in HER2-low MBC
Hope Rugo, Professor of Medicine at the University of California, San Francisco, shared a post…
Apr 19, 2025, 18:29 | Insight
ESMO living guidelines on metastatic breast cancer
European Society for Medical Oncology (ESMO) shared a post on X: "ESMO Living Guidelines on…
Mar 25, 2025, 18:59 | Blog
Evandro de Azambuja: Attending the first French-Belgian meeting for patients with metastatic breast cancer
Evandro de Azambuja, BSMO President 2023-2026, shared a post on LinkedIn: "Some members of the…
Mar 9, 2025, 15:01 | Blog
Sami Mansfield: Racial disparities in recommending PI3K inhibitors in black women with mBC
Sami Mansfield, Founder of Cancer Wellness for Life, shared a post on LinkedIn: "New study…
Mar 3, 2025, 11:36 | Insight
Racial Disparities in ctDNA Profiles and Targeted Therapy in mBC - International Society of Liquid Biopsy
International Society of Liquid Biopsy (ISLB) shared a post on X about a paper by…
Feb 20, 2025, 09:40 | Science
Mihaela Stana: The spectrum of adverse events during mBC treatment with ADCs
Mihaela Stana, Oncology Specialist at Elysee Hospital, shared a post on LinkedIn about a paper…
Feb 18, 2025, 16:33 | Blog
Elene Kekelia: First Young Doctors’ Conference on Metastatic Breast Cancer in Georgia
Elene Kekelia, University Lecturer at Petre Shotadze Tbilisi Medical Academy (TMA), shared a post on…
Feb 11, 2025, 10:28 | Blog
Paolo Tarantino: A lecture on novel treatments for HR+/HER2- MBC at IPO-Porto
Paolo Tarantino, Advanced research fellow at Dana-Farber Cancer Institute, shared a post on LinkedIn: "Back…
Feb 11, 2025, 08:06 | Blog
The Evolving Role of Liquid Biopsy in HR+/HER2- Metastatic Breast Cancer - International Society of Liquid Biopsy
International Society of Liquid Biopsy shared a post on X: "ISLB-Endorsed Seminar: The Evolving Role…
Feb 9, 2025, 15:15 | Science
Elvina Almuradova: Survival outcomes for ERBB2-positive MBC patients with brain metastases
Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology (IEO), shared an…
Feb 3, 2025, 14:40 | Blog
Paolo Tarantino: Fixed dose of capecitabine vs standard dose for Metastatic Breast Cancer
Paolo Tarantino, Advanced research fellow at Dana-Farber Cancer Institute, posted on X about recent paper…
Jan 30, 2025, 08:44 | Science
Final analysis of the PRECIOUS phase 3 trial
Paolo Tarantino, Clinical Fellow at Dana-Farber Cancer Institute and Harvard Medical School, shared an article by…
Jan 23, 2025, 14:32 | Blog
Exciting progress in metastatic breast cancer research - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared the following on X: “Exciting progress in Metastatic Breast Cancer…
Jan 21, 2025, 06:43 | Blog
SPCC: Outlook for the HR+/HER2- MBC treatment landscape in 2025 and beyond
SPCC (Sharing Progress in Cancer Care) shared the following on LinkedIn: “HR+/HER2- MBC treatment landscape:…
Jan 19, 2025, 13:52 | Insight
Amol Akhade: Datopotomab deruxtecan got approved for HR+ HER2- MBC in the third line
Amol Akhade, Consultant Medical Oncologist and Hemato-oncologist at Suyog Cancer Clinics, shared a post on…
Jan 17, 2025, 14:35 | Science
Elisa Agostinetto: The Preferable-Effect trial is now out
Elisa Agostinetto, Medical Oncologist at the Brussels University Hospital, posted on X, about recent paper…
Jan 15, 2025, 13:54 | Blog
FDA Fast Tracks Emiltatug Ledadotin in Advanced or Metastatic Breast Cancer
The FDA granted a new fast track designation to emiltatug ledadotin for the treatment of…
Jan 13, 2025, 19:41 | Blog
Professor Gianluca Franceschini: Advancing Breast Cancer Surgery - Mediamedic
Mediamedic shared a post on LinkedIn: "Professor Gianluca Franceschini: Advancing Breast Cancer Surgery. We are…
Jan 13, 2025, 13:04 | Blog
Outlook for the HR+/HER2- MBC treatment landscape in 2025 and beyond by SPCC
Outlook for the HR+/HER2- MBC treatment landscape in 2025 and beyond by SPCC will be…
Jan 13, 2025, 10:23 | Science
The Randomized Noninferiority Phase III EMERALD Trial on HER2+ Locally Advanced/Metastatic Breast Cancer
A recent paper by Toshinari Yamashita et al. was published in the Journal of Clinical…
Jan 10, 2025, 14:23 | Insight
Janice Cowden: Accurate counting and research funding for metastatic breast cancer
Janice Cowden, Former nurse, Cancer patient and Advocate, shared a post on X by Ann…
Jan 7, 2025, 17:29 | Science
Nicolas Hart: Assessing cognitive function in metastatic breast cancer survivors
Nicolas Hart, Associate  Professor at the National Health and Medical Research Council, shared a post…
Dec 27, 2024, 13:51 | Insight
Arvinas has joined Metastatic Breast Cancer Alliance as an Industry Member
Metastatic Breast Cancer Alliance shared a post on LinkedIn: “ICYMI: Arvinas joined us as an…
Dec 20, 2024, 17:25 | Blog
Our PCORI-funded CDK study has officially enrolled its first patient at Ironwood Cancer Center - ASCO
ASCO made the following post on X: “Exciting news! Our PCORI-funded CDK study has officially…
Dec 20, 2024, 17:18 | Blog
Julia Maués' SABCS 2024 highlights - Breast Cancer Research Foundation
Breast Cancer Research Foundation shared the following on X: “Last week, we were on the…
Dec 18, 2024, 11:33 | Blog
Sally Wolf: Full Circle Moments Remind Us to Reflect
Sally Wolf, CEO and Founder of LightWorks, shared a post on LinkedIn: “Full circle moments…
Dec 16, 2024, 08:20 | Blog
Francisco J. Esteva: Addressing gaps in real-world oncology care through data studies
Francisco J. Esteva, Professor of Medicine at Zucker School of Medicine and Chief of Division…
Dec 15, 2024, 10:54 | Blog
Elvina Almuradova: EMBER-3 trial highlights imlunestrant for metastatic breast cancer
Elvina Almuradova, Associate Professor at Medicana Health Group, posted the following on LinkedIn: “The EMBER-3 trial…
Dec 15, 2024, 09:42 | Insight
Lisa Carey and Otto Metzger, discuss about the phase 3 PATINA trial
SABCS shared a post on X: “Now on SABCS Snippets: Lisa Carey and Otto Metzger,…
Dec 15, 2024, 01:17 | Blog
Amol Akhade: How to treat metastatic breast cancer at the end of 2024
Amol Akhade, Senior Consultant Medical Oncologist and Hemato-oncologist at Suyog Cancer Clinics and Reliance Hospitals,…
Dec 14, 2024, 06:34 | Blog
Immediate Subsequent lines of therapy after T-DXd in Metastatic Breast Cancer - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: "SABCS24 POSTER SESSION | P1-08-08 |…
Dec 2, 2024, 13:48 | Blog
Janice Cowden: Excited to share that I’ve been invited to serve as a social media ambassador at SABCS 2024
Janice Cowden, Former nurse, Cancer patient and Advocate, shared a post on LinkedIn by OncoDaily,…
Nov 16, 2024, 09:57 | Blog
Targeting expression in metastatic breast cancer - ASCO
ASCO posted the following on X: “Though ADCs have emerged as a cutting-edge approach to…
Nov 9, 2024, 20:45 | Blog
Sophie Blake: Honoured to be included in the Top 100 list of X Influencers in Breast Cancer by OncoDaily
Sophie Blake shared a post on X: "I am honoured to be included in the Top…
Nov 8, 2024, 19:01 | Insight
Predictors of Response to CDK4/6i Rechallenge in ER+ Metastatic Breast Cancer
Sergio Cifuentes Canaval, Medical Oncology Fellow at National Autonomous University of Mexico, shared a post…
Nov 5, 2024, 15:32 | Blog
Carmen Criscitiello: SERENA-2 and INAVO120 offering fresh insights on targeted approaches in MBC
Carmen Criscitiello, Medical Oncologist at IEO and Associate Professor at University of Milan, posted on…
Nov 5, 2024, 00:59 | Blog
Ginny Mason: Remembering all the inflammatory and metastatic breast cancer souls I've known in the 30 years since my own diagnosis
Ginny Mason, Executive Director of the Inflammatory Breast Cancer Research Foundation, shared a post on…
Nov 3, 2024, 16:25 | Blog
Raising awareness on biomarker information gaps for metastatic breast cancer patients - ABC Global Alliance
ABC Global Alliance shared the following on LinkedIn: “Did you know 56% of patients didn’t…
Nov 2, 2024, 03:33 | Blog
More and more women are living longer with metastatic breast cancer - Africa Cancer Foundation
Africa Cancer Foundation shared the following on X: "More and more women are living longer…
Nov 1, 2024, 14:35 | Blog
Francisco J. Esteva: The standard of care for hormone receptor-positive, HER2-negative metastatic breast cancer
Francisco J. Esteva, Chief, Division of Hematology and Medical Oncology, Lenox Hill Hospital, shared a post on…
Oct 31, 2024, 17:16 | Blog
Monica Steigerwald: Gilead Sciences announced its amazing allocation of $3.15 million to 22 organizations
Janice Cowden, Former nurse, cancer patient and advocate, shared a post by Monica Steigerwald, Vice President…
Oct 31, 2024, 10:10 | Insight
Evaluating the Efficacy of Scalp Cooling on Hair Loss in Patients with Metastatic Breast Cancer: A Phase II Clinical Trial
We are pleased to announce the enrollment of participants for a pivotal Phase II clinical…
Oct 31, 2024, 08:59 | Insight
Self-directed online psychosocial intervention for women with metastatic breast cancer - MASCC
Multinational Association of Supportive Care in Cancer (MASCC) shared a post on X about a recent paper…
Oct 30, 2024, 19:17 | Blog
Ginny Mason: When is SEER going to start counting and keeping tabs on breast cancer patients?
Ginny Mason, Executive Director of the Inflammatory Breast Cancer Research Foundation, shared a post by Living…
Oct 25, 2024, 09:05 | Dialogues
ASCO24 Updates: Dr. Xin Hu on Early Palliative Care in Advanced Cancer
The American Society of Clinical Oncology (ASCO) Annual Meeting is one of the largest and most…
Oct 24, 2024, 16:10 | Blog
Lisa Beatty: Digital Mental Health Intervention for women with Metastatic Breast Cancer
Lisa Beatty, Associate Professor in Clinical Psychology at Flinders University, shared on X: "Its Breast…
Oct 19, 2024, 10:51 | Blog
Tracey O'Brien: Our state is the first jurisdiction in the world to accurately determine people living with metastatic breast cancer
Tracey O'Brien shared a post on LinkedIn: "Making sure people with cancer are seen and heard…
Oct 14, 2024, 11:50 | Blog
Sally Wolf: Pure pink doesn't include metastatic breast cancer
Sally Wolf, CEO and Founder, LightWorks, shared a post on LinkedIn: "If you loved the…
Oct 13, 2024, 12:08 | Blog
National Metastatic Breast Cancer Awareness Day 2024
National Metastatic Breast Cancer Awareness Day is celebrated on October 13th to shed light on…
Oct 12, 2024, 11:21 | Insight
How to determine optimal treatment for de novo metastatic breast cancer
Fumiko Ladd Chino shared a post on X: "Dr Jennifer Plichta, Duke Cancer Breast Surgical Oncology…
Oct 10, 2024, 16:44 | Blog
Giuseppe Curigliano: With T-DXd for HR-Positive Metastatic Breast Cancer
Giuseppe Curigliano shared an article on X: "DESTINY-Breast06 Shows Significant PFS Improvement With T-DXd for HR-Positive…
Oct 8, 2024, 12:41 | Blog
The Ending Metastatic Breast Cancer for Everyone Program - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared on X: "Join Kristina Fanucci, MD, and Antonio Giordano, MD, PhD,…
Oct 6, 2024, 14:01 | Insight
MD Anderson Research Highlights
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in…
Oct 6, 2024, 10:34 | Blog
Vicki Durston: Enhancing outcomes for individuals diagnosed and living with Metastatic Breast Cancer
Vicki Durston shared on LinkedIn: "Coming to you from Lisbon, Portugal during Breast Cancer Awareness…
Oct 4, 2024, 10:15 | Blog
The first prospective trial of sacituzimab govitecan (+ trastuzumab) after T-DXd for HER2+ MBC
Paolo Tarantino shared a post by Dana-Farber’s Breast Oncology Center on X, adding: "There’s few open questions as…
Sep 30, 2024, 17:12 | Blog
Delving into the Latest Advancements in Metastatic Breast Cancer - The Breast Cancer Research Foundation
The Breast Cancer Research Foundation posted the following on LinkedIn: “With Metastatic Breast Cancer Awareness…
Sep 28, 2024, 14:00 | Blog
Paolo Tarantino: How do the results of DESTINY-Breast06 change our practice?
Paolo Tarantino shared on LinkedIn: "How do the results of DESTINY-Breast06 change our practice? Should…
Sep 26, 2024, 15:04 | Insight
Stephanie Graff: Ever wondered what 'clinically meaningful' really means
Stephanie Graff shared a post on X: "Ever wondered what 'clinically meaningful' really means? We sought…
Sep 23, 2024, 14:23 | Insight
Stephanie Graff: What ‘clinically meaningful’ actually means
Stephanie Graff shared on LinkedIn: “We have all heard the phrase ‘clinically meaningful’ from the…
Sep 16, 2024, 04:57 | Blog
The latest insights on ADCs for HR-Positive, HER2-low metastatic breast cancer - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: ''Paolo Tarantino will discuss the latest…
Sep 14, 2024, 06:02 | Blog
Emad Shash: Excited to share our three poster abstracts accepted for presentation at ESMO Congress 2024!
Emad Shash, General Manager of the Breast Cancer Comprehensive Center of the National Cancer Institute at…
Sep 10, 2024, 13:50 | Blog
Francisco J. Esteva: The importance of improving ctDNA methodologies
Francisco J. Esteva, Chief, Division of Hematology and Medical Oncology at Lenox Hill Hospital shared…
Sep 9, 2024, 08:35 | Blog
Carmine Valenza: Our contribution regarding ESR1m, endocrine-responsive metastatic breast cancer
Carmine Valenza, MPH Student at Harvard T.H. Chan School of Public Health, shared a post…
Sep 4, 2024, 06:49 | Insight
Vicki Durston: Sarah Lee flying the flag for the benefits of exercise in living well with MBC
Vicki Durston, President of the General Assembly and Board Member of ABC Global Alliance, shared…
Aug 27, 2024, 17:21 | Insight
Review of precision therapeutics and emerging strategies in HR+ MBC
Michelle DeMeo, Senior Program Manager at Dana-Farber Cancer Institute, shared on X: "Congratulations to Maxwell…
Aug 25, 2024, 13:11 | Insight
How do SDOHs impact access to care for metastatic breast cancer patients - ACCC
Association of Cancer Care Centers (ACCC) shared a post on LinkedIn: "How do social drivers…
Aug 25, 2024, 13:09 | Blog
Allison Zibelli and Erika Hamilton discussing data from the DESTINY-Breast06 and A-BRAVE trials
Sidney Kimmel Comprehensive Cancer Center at Jefferson shared a post on LinkedIn: "Dr. Allison Zibelli,…
Aug 23, 2024, 16:14 | Blog
Practice changing updates on Metastatic Breast Cancer with Dr. Nan Chen - University of Chicago Hematology
University of Chicago Hematology shared a post on X: "This Saturday and Sunday Dr. Nan Chen…
Aug 22, 2024, 12:17 | Insight
Jame Abraham: we need to have a better understanding of HER-2 ultra-low and how to define it
Jame Abraham shared on X: "New approval for TDXd for metastatic breast cancer with HER…
Aug 12, 2024, 14:01 | Blog
Vicki Durston: Survey for clinicians and individuals impacted by metastatic breast cancer
Vicki Durston, Strategic Advisor, Specialist Direct at Specialist Direct Ptv Ltd, shared a post on…
Aug 10, 2024, 13:12 | Insight
Piotr Wysocki: Supervised, structured and individualized exercise improves the quality of life for metastatic breast cancer patients
Piotr Wysocki recently shared on LinkedIn: "A recent study published in Nature Medicine, led by Anouk…
Aug 6, 2024, 07:06 | Blog
Janice Cowden: 15 minute survey for metastatic breast cancer
Janice Cowden shared a post by ABC Global Alliance, on LinkedIn, adding: ''Please, if you…
Aug 6, 2024, 02:02 | Insight
Trastuzumab deruxtecan therapy in patients with HER2-positive metastatic breast cancer
Francisco Esteva, Chief of Division of Hematology and Medical Oncology at Lenox Hill Hospital, shared…
Aug 5, 2024, 17:35 | Blog
Sandy Cassanelli: Honored to have Eric Winer interview me for my work at breast friends fund
Sandy Cassanelli, the CEO of Greenough Packaging and Maintenance Supplies and Breast Friends Fund-Funding Research…
Aug 4, 2024, 23:45 | Stories
Abigail Johnston: To say that my anxiety is flaring is a bit of an understatement
Abigail Johnston,Director of Mentorship at Project LIFE MBC, shared on X: "Scanxiety... Tomorrow is my…
Jul 27, 2024, 11:23 | Insight
Anouk Hiensch: Exercise improves quality of life in patients with metastatic breast cancer
Anouk Hiensch, Assistant Professor at UMC Utrecht, shared a post on X about his recent…
Jul 10, 2024, 17:46 | Blog
Gary L. Thompson: Lesley Fallowfield exploring ways to enable clinicians and genetic counselors to discuss challenging topics
Gary L. Thompson, Board Chair of Side-Out Foundation, shared on X: “Day 208/262 of my…
Jul 8, 2024, 18:14 | Insight
Paolo Tarantino: What is HER2 « ultralow » breast cancer, and why should you care?
Paolo Tarantino shared on X: “What is HER2 « ultralow » breast cancer, and why…
Jul 8, 2024, 15:07 | Blog
To say that we are heartbroken about losing our dear Marlena Murphy is an understatement - PIK3CA Path Breakers
PIK3CA Path Breakers shared on X: “To say that we are heartbroken about losing our…
Jul 8, 2024, 12:44 | Insight
Tatiana Prowell: Another person with Metastatic Breast Cancer taken too soon
Tatiana Prowell shared a post on X: “I am so grateful that I had the…
Jun 26, 2024, 03:18 | Insight
Paolo Tarantino: The 5 S rules help memorizing a simple framework to manage ILD
Paolo Tarantino shared on LinkedIn: “T-DXd is rapidly expanding in indications, from HER2+, to HER2-low, and…
Jun 25, 2024, 16:01 | Insight
Paolo Tarantino: Phase 1 trial of the HER2 topo1 ADC SHR-A1811 out in Journal of Clinical Oncology
Paolo Tarantino shared on X:  . "Phase 1 trial of the HER2 topo1 ADC SHR-A1811…
Jun 19, 2024, 12:33 | Blog
Maria Babak: How Bevacizumab is revolutionizing treatment for multiple cancers
Maria Babak shared a post by CityU iGEM on LinkedIn: "Discover how Bevacizumab, a powerful cancer…
Jun 15, 2024, 04:53 | Insight
Felipe Rodrigues: Excited to share our work on the reciprocal interaction between metastatic cancer cells and AT2 cells
Felipe Rodrigues, Postdoctoral Researcher at Rockefeller University, recently shared a post on X: "Beyond excited…
Jun 14, 2024, 21:00 | Blog
Michail Ignatiadis: Humble to have led this EBCC14 manifesto
Quoting Michail Ignatiadis, Director of Breast Medical Oncology Clinic and Program, Jules Bordet Institute, on…
Jun 10, 2024, 16:25 | Blog
Vicki Durston: Thrilled to announce the launch of our new Metastatic Breast Cancer Media Guide
Vicki Durston, President of the General Assembly and Board Member at ABC Global Alliance, shared…
Jun 10, 2024, 07:18 | Blog
Francisco J. Esteva: Emerging technologies are set to revolutionize the detection and application of biomarkers in cancer treatment
Francisco J. Esteva, Chief of the Division of Hematology and Medical Oncology at Lenox Hill…
Jun 6, 2024, 00:29 | Blog
Paolo Tarantino: Expansion cohorts from TBCRC by Nadine Tung
Paolo Tarantino shared a post on X: “One of the most important presentations of ASCO24:…
Jun 5, 2024, 15:22 | Insight
Piotr Wysocki: T-DXd in metastatic ER+/HER2-low breast cancer patients after endocrine treatment failure
Piotr Wysocki recently posted on LinkedIn: "Results of a Destiny-Breast06 trial have been presented by…
May 31, 2024, 15:41 | Societies
Paolo Tarantino: More than 25 ASCO24 oral presentations by Dana-Farber Cancer Institute researchers
Paolo Tarantino shared a post by Dana-Farber Cancer Institute on X: "More than 25 ASCO24…
May 27, 2024, 04:24 | Blog
Nazik Hammad: An honour to be part of the 2024 Best Health for Black Women virtual event
Nazik Hammad shared a post by Women's College Hospital, on LinkedIn: "Canadian Black women getting together…
May 24, 2024, 00:58 | Blog
Francisco J. Esteva on the DESTINY-Breast06 trial
Francisco J. Esteva, Chief of Division of Hematology and Medical Oncology at Lenox Hill Hospital, shared…
May 23, 2024, 12:46 | Blog
ESMO - This novel combination therapy holds great promise for BRCA-mutated metastatic Breast Cancers
ESMO shared a post on LinkedIn: "ESMOBreast24: phase 2 data on combining olaparib, durvalumab, and fulvestrant…
May 23, 2024, 11:18 | Insight
Top 5 articles of the week in Cancer Network
Cancer Network shared on X: "View the top 5 articles of the week: FDA Approves…
12
All: 139 Posts: 1 - 100
Special Coverage